المؤلفون: M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya, V. P. Kovtun, V. A. Volkov, A. A. Movsesyants

المصدر: Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 2, Pp 78-86 (2018)

مصطلحات موضوعية: гемофильная инфекция типа b (hib-инфекция), капсульные полисахариды, вакцинопрофилактика, календарь прививок, полирибозилрибитолфосфат (prp), полисахаридные вакцины, конъюгированные вакцины, комбинированные вакцины, haemophilus influenzae type b (hib-infection), capsular polysaccharides, preventive vaccination, immunization schedule, polyribosylribitolphosphate (prp), polysaccharide vaccines, conjugate vaccines, combination vaccines, Biotechnology, TP248.13-248.65, Medicine

وصف الملف: electronic resource

Relation: https://www.biopreparations.ru/jour/article/view/85; https://doaj.org/toc/2221-996X; https://doaj.org/toc/2619-1156

URL الوصول: https://doaj.org/article/acf673a0557c4af985024d1b7138acd0

المؤلفون: M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya, V. P. Kovtun, V. A. Volkov, A. A. Movsesyants, М. В. Абрамцева, А. П. Тарасов, Т. И. Немировская, В. П. Ковтун, В. А. Волков, А. А. Мовсесянц

المصدر: Biological Products. Prevention, Diagnosis, Treatment; Том 17, № 2 (2017); 78-86 ; БИОпрепараты. Профилактика, диагностика, лечение; Том 17, № 2 (2017); 78-86 ; 2619-1156 ; 2221-996X ; undefined

مصطلحات موضوعية: combination vaccines, капсульные полисахариды, вакцинопрофилактика, календарь прививок, полирибозилрибитолфосфат (PRP), полисахаридные вакцины, конъюгированные вакцины, комбинированные вакцины, haemophilus influenzae type b (Hib-infection), capsular polysaccharides, preventive vaccination, immunization schedule, polyribosylribitolphosphate (PRP), polysaccharide vaccines, conjugate vaccines

وصف الملف: application/pdf

Relation: https://www.biopreparations.ru/jour/article/view/85/54; Haemophilus influenzae bacteria. NIBSC/SCIENCE PHOTO LIBRARY. Available from: http://www.sciencephoto.com/media/ 11458/view.; Богданович ТМ, Стецюк ОУ, Кречикова OИ, Боронина ЛГ, Катосова ЛК, Фаустова МЕ. Страчунский ЛС, ред. Выделение, идентификация и определение чувствительности к антибиотикам Haemophilus influenzae. Клиническая микробиология и антимикробная химиотерапия 2000; 2(2): 93-109.; Pfieffer R. Die Aetiologie der Influenza. Z Hyg Infect. 1893; 13: 357-86.; Epidemiology and prevention of vaccine-preventable diseases: The Pink Book: Course Textbook. 12th ed. Second Printing (May 2012). Available from: https://goo.gl/e6EOQy.; Tognotti E. Scientific triumphalism and learning from facts: bacteriology and the «Spanish flu» challenge of 1918. Soc Hist Med. 2003; 16(1): 97-110.; Haemophilus influenzae type b (Hib) Vaccination Position Paper. WHO. Weekly epidemiological record 2013; 88(39): 413-28.; Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374(9693): 903-11.; Moxon ER, Kroll JS. The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol. 1990; 150: 65-85.; Crisel RM, Baker RS, Dorman DE. Capsular polymer of Haemophilus influenzae, type b. I: Structural characterization of the capsular polymer of strain Eagan. J Biol Chem. 1975; 250(13): 4926-30.; Chandran A, Watt JP, Santosham M. Haemophilus influenzae vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 6th ed. Philadelphia, PA, Saunders-Elsevier; 2013. P. 560-621.; Mu XQ, Egelman EH, Bullitt E. Structure and function of Hib pili from Haemophilus influenzae type b. J Bacteriol. 2002; 184(17): 4868-74.; Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N. Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014; 63 (RR-01): 1-14.; Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol. 1933; 24: 273-84.; Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983; 147(6): 1100.; Notifiable diseases and mortality tables. Morbidity and Mortality Weekly Report (MMWR) 2015; 64(01): ND-1-ND-19. Available from: https://goo.gl/YTRlV9.; МР 3.3.1.0001-10 Эпидемиология и вакцинопрофилактика инфекции, вызываемой Haemophilus influenzae типа b. Методические рекомендации. 2010.; Chandrasekar PH, Cavaliere R, Rust RS, S Swaminathan. Haemophilus meningitis. Available from: https://goo.gl/NGBAEI.; Озерецковский НА, Немировская ТИ. Вакцинация против гемофильной инфекции типа b в Российской Федерации и за рубежом. Эпидемиология и вакцинопрофилактика 2016; 15(1): 61-6.; Учайкин ВФ, Шамшева ОВ, Михайлова ЕВ, Шведова НМ. Национальный календарь профилактических прививок России: проблемы и пути их решения, результаты реализации в Саратовской области (обзор). Саратовский научно-медицинский журнал 2013; 9(2): 192-6.; O’Neill JM, St Geme JW 3rd, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, Schutze GE. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol. 2003; 41(7): 3064-9.; Faden H, Duffy L, Williams A, Krystofik DA, Wolf J. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life. J Infect Dis. 1995; 172(1): 132-5.; Cochi SL, Fleming DW, Hightower AW, Limpakarnjanarat K, Facklam RR, Smith JD, et al. Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr. 1986; 108(6): 887-96.; Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, El Arifeen S, et al. Invasive Haemophilus influenzae type b diseases in Bangladesh, with increased resistance to antibiotics. J Pediatr. 2005; 146(2): 227-33.; Adegbola RA, Mulholland EK, Secka O, Jaffar S, Greenwood BM. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. J Infect Dis. 1998; 177(6): 1758-61.; Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000; 13(2): 302-17.; Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenzae type b conjugate vaccines. Immunology 2004; 113(2): 163-74.; Käyhty H, Karanko V, Peltola H, Mäkelä PH. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 1984; 74(5): 857-65.; Peltola H, Käyhty H, Sivonen A, Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977; 60(5): 730-7.; Centers for Disease Control (CDC). Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. MMWR Morb Mortal Wkly Rep. 1985; 34(15): 201-5.; Dajani AS, Asmar BI, Thirumoorthi MC. Systemic Haemophilus influenzae disease: an overview. J. Pediatr. 1979; 94(3): 355-64.; Avery OT, Goebel WF. Chemo-immunological studies on conjugated carbohydrate-proteins : V. The immunological specifity of an antigen prepared by combining the capsular polysaccharide of type III Pneumococcus with foreign protein. J Exp Med. 1931; 54(3): 437-47.; Абрамцева МВ, Тарасов АП, Немировская ТИ. Менингококковая инфекция. Конъюгированные полисахаридные менингококковые вакцины и вакцины нового поколения. Сообщение 3. Биопрепараты. Профилактика, диагностика, лечение 2016; 16(1): 3-13.; Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Vaccine 1993; 11(Suppl 1): S46-S51.; Barington T, Gyhrs A, Kristensen K. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun. 1994; 62(1): 9-14.; Mäkelä PH, Käyhty H, Leino T, Auranen K, Peltola H, Ekström N, Eskola J. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine 2003; 22(2): 287-92.; Haemophilus influenzae type b (Hib): the green book. Chapter 16. Immunization against infections desease. 2013. Available from: https://goo.gl/vYT2f3.; Canadian immunization guide: Part 4 - Active vaccines. Haemophilus influenzae type b vaccine. 2014. Available from: https://goo.gl/ qgro1Z.; Haemophilus influenzae infections. Red Book. 29 ed.; Am Acad Pediatr. 2012. P. 345-52. Available from: https://goo.gl/sAmyoC.; Adams DA, Jajosky RA, Ajani U, Kriseman J, Sharp P, Onwen DH, et al. Summary of notifiable diseases - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014; 61(53): 1-121.; Harris JB, Gacic-Dobo M, Eggers R, Brown DW, Sodha SV. Global routine vaccination coverage, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63(46): 1055-8.; Groups with special vaccination requirements. The Australian immunization Handbook 10th, 2015. Available from: http://www.im- munise.health.gov.au/7A5C97D9-EFF7-46D7-A8B8-AB0E73A4852E/ FinalDownload/DownloadId-E531F400104334DF0A8EAE21ECC5 39EA/7A5C97D9-EFF7-46D7-A8B8-AB0E73A4852E/internet/im- munise/publishing.nsf/content/7B28E87511E08905CA257D4D00 1DB1F8/$File/Aus-Imm-Handbook.pdf.; Washburn LK, O’Shea TM, Gillis DC, Block SM, Abramson JS. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr. 1993; 123(5): 791-4.; Heath PT, Booy R, McVernon J, Bowen-Morris J, Griffiths H, Slack MP, et al. Hib vaccination in infants born prematurely. Arch Dis Child. 2003; 88(3): 206-10.; Kristensen K, Gyhrs A, Lausen B, Barington T, Heilmann C. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J. 1996; 15(6): 525-9.; Национальный календарь профилактических прививок. Available from: https://goo.gl/CtAqe5.; WHO information sheet observed rate of vaccine Haemophilus influenzae type b (Hib) vaccine. April 2012. Available from: https://goo.gl/ezGiwx.; Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003; 112(4): 815-20.; Moro PL, Jankosky C, Menschik D, Lewis P, Duffy J, Stewart B, Shimabukuro TT. Adverse events follow Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. J Pediatr. 2015; 166(4) 992-7.; МУ 3.3.1.1095-02. Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок. Методические указания. 2002.; https://www.biopreparations.ru/jour/article/view/85; undefined

الاتاحة: https://www.biopreparations.ru/jour/article/view/85